Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Change in Receivables (2024 - 2025)

Historic Change in Receivables for Onconetix (ONCO) over the last 2 years, with Q3 2025 value amounting to -$9559.0.

  • Onconetix's Change in Receivables rose 8813.73% to -$9559.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$92841.0, marking a year-over-year change of. This contributed to the annual value of -$116676.0 for FY2024, which is 28732.3% down from last year.
  • As of Q3 2025, Onconetix's Change in Receivables stood at -$9559.0, which was up 8813.73% from -$6232.0 recorded in Q2 2025.
  • In the past 5 years, Onconetix's Change in Receivables ranged from a high of $116763.0 in Q1 2024 and a low of -$85262.0 during Q2 2024